Layth Saleh, MD
Clinical Cardiac Electrophysiology · Lakewood, CONPI 1427201938
Payments from drug & device makers
Across 381 payments — averaging $463.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cordis US CORP.$163K
- Abbott$2K
- Medtronic$2K
- Biosense Webster, Inc.$2K
- Boston Scientific$2K
- Medical Device Business Services, Inc.$2K
- plus $5K from 32 others
Across 1 payment — averaging $1450.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cordis US CORP.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cordis US CORP. | 5 | $162,613 |
| Abbott | 45 | $2,149 |
| Medtronic(3 entities) | 32 | $2,062 |
| Biosense Webster, Inc. | 64 | $1,955 |
| Boston Scientific | 55 | $1,802 |
| Medical Device Business Services, Inc. | 5 | $1,541 |
| Amgen | 20 | $475 |
| E.r. Squibb & Sons, L.L.C. | 23 | $464 |
| Johnson & Johnson | 12 | $351 |
| Impulse Dynamics (USA) Inc. | 7 | $350 |
| Novartis | 19 | $337 |
| Sanofi-aventis U.S. LLC | 15 | $293 |
| Atricure, Inc. | 4 | $265 |
| Baxter Healthcare | 3 | $252 |
| Cvrx, Inc. | 4 | $223 |
| Pfizer | 12 | $209 |
| Abiomed | 3 | $179 |
| Cardiovascular Systems Inc. | 2 | $135 |
| Merck | 8 | $127 |
| Boehringer Ingelheim | 7 | $126 |
| Astellas Pharma US Inc | 2 | $114 |
| Shockwave Medical, Inc | 1 | $98 |
| Bardy Diagnostics, Inc. | 5 | $83 |
| AstraZeneca | 4 | $67 |
| Alnylam Pharmaceuticals Inc. | 3 | $60 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $60 |
| Heartflow, Inc. | 2 | $56 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $49 |
| Amarin Pharma, Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Akcea Therapeutics, Inc. | 1 | $24 |
| Vifor Pharma, Inc. | 1 | $23 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $22 |
| Inogen, Inc. | 1 | $18 |
| Angiodynamics, Inc. | 1 | $18 |
| BD | 1 | $17 |
| Novo Nordisk | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $11 |
How this compares
$176,714 in reported general payments places this provider in the 85th percentile of 66 clinical cardiac electrophysiology providers in Colorado.
See all clinical cardiac electrophysiology providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical cardiac electrophysiology in Lakewood
- Ganesh VenkataramanLakewood$842K
- Srikanth SundaramLittleton$2.1M
- Bradley MikaelianColorado Springs$617K
- Wendy TzouAurora$538K
- Christopher PorterfieldAurora$533K
- Benjamin SteinbergDenver$383K
- Amar TrivediLoveland$380K
- Ethan EllisFort Collins$307K
- Margot VlokaAurora$293K
- Christopher ColeColorado Springs$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.